Skip to content
★ Sign in to follow
XI

Xi'an International Medical Investment Company Limited Stock: price and insider trades · China

国际医学

CN·Mcap CN¥9.6BHealth Care

No insider purchase over the last 90 days. The latest, by 刘瑞轩, was filed 13 May 2026.

Xi'an International Medical Investment Company Limited: what insiders have been doing

This page follows insider dealings at Xi'an International Medical Investment Company Limited as filed with SSE / SZSE (CSRC), a company from the Health Care sector. In the past year (4 November 2025 to 4 November 2026), 1 filing came from 1 insider.

Not one open-market sale was filed. On the buying side, 1 insider reported 1 purchase totalling €57k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Among those who bought: 1 board member. One trade stands out by size: a purchase of €57k from 刘瑞轩, disclosed on 13 May 2026.

With 1 filing in twelve months, the company is quieter than the median of 2 filings across the 521 companies we follow on the same exchange. Since 2021, the database holds 5 purchases and 4 sales by insiders of the company.

The most recent open-market purchase was published on 13 May 2026, 180 days ago.

In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.

Insider Decl.
9
Thresholds
n/a
Buy Volume
€179,165
5 ops. · all time
Sell Volume
€19M
4 ops. · all time

Who traded when

BuySale
刘瑞轩1 buy
李富有1 buy

Since the insiders bought

  • Filed 13 May 2026 · 180 days ago · €57k
    +0.7%
    Entry CN¥4.47 · Close 02 Nov 2026 CN¥4.50
  • Filed 09 Apr 2025 · 579 days ago · €3,153
    -9.8%
    Entry CN¥5.23 · Close at T+365 CN¥4.72
  • Filed 23 Sept 2021 · 1873 days ago · €15k
    -20.4%
    Entry CN¥11.59 · Close at T+365 CN¥9.22

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 23,415 of 26,911 companies
24.8
score / 100
Value
38
Quality
12
FCF yld11%
Earn yld-3.2%
EV/EBITDA32.6x
ROE-10%
Gross mgn8.3%
Net mgn-7.7%
Debt/EBITDA9.9x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥4.31
Analyst consensus
1 analysts
1.00/5
CN¥5.70Target CN¥5.70(+32%)CN¥5.70
Income statement
RevenueCN¥4.1B
Gross profitCN¥336.4M8% margin
EBITDACN¥425.6M10% margin
Net income-CN¥313.1M-5.2% margin
Valuation
P/Book3.0x
Beta0.17
Balance sheet & cash
Market capCN¥9.6B
Total debtCN¥4.2B
Free Cash FlowCN¥1B
Debt / Equity106%
Profitability & ownership
ROE-10.5%
ROA-1.2%
% insiders33.2%
% institutions1.0%
Last declaration on 13 May 2026
Declarations9 total
  • ▲
    董事,高管Executives
    455,000 CNY11SZSE
    100,000 shares35.4% of flowA股XSHESZSE:273000000610942500
    Canonical exit: 11 Aug 2026 (T+90)
  • ▲
    独立董事Executives
    25,382 CNY15SZSE
    4,900 shares84.4% of flowA股XSHESZSE:173000008783631070
    Canonical exit: 8 Jul 2025 (T+90)
  • ▲
    董事,高管Executives
    435,000 CNY10SZSE
    50,000 shares35.0% of flowA股XSHESZSE:173000006654814270
    Canonical exit: 10 Sept 2023 (T+90)
  • ▼
    董事Executives
    138M CNY15SZSE
    12,300,000 shares100.0% of flowA股XSHESZSE:173000006364642880
  • ▼
    董事,高管Executives
    125,600 CNY24SZSE
    10,000 shares54.0% of flowA股XSHESZSE:173000006116496960
  • ▼
    独立董事Executives
    4,296 CNY9SZSE
    400 shares15.6% of flowA股XSHESZSE:173000006041482240
  • ▲
    董事,总裁Executives
    334,000 CNY25SZSE
    50,000 shares29.6% of flowA股XSHESZSE:173000005367414140
    Canonical exit: 14 Jun 2022 (T+90)
  • ▼
    监事Executives
    24,000 CNY15SZSE
    2,000 shares100.0% of flowA股XSHESZSE:173000005183254850
  • ▲
    董事,高管Executives
    111,000 CNY12SZSE
    10,000 shares46.0% of flowA股XSHESZSE:173000004904946180
    Canonical exit: 22 Dec 2021 (T+90)

9 of 9 declarations

About Xi'an International Medical Investment Company Limited

国际医学 is a company focused on the healthcare and pharmaceutical sector, providing various medical services and pharmaceutical products. It is listed on the XSHE market.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations